Related Experiment Video
Updated: Jun 26, 2026
06:23
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
Published on: October 13, 2016
[MCI-plus: mild cognitive impairment with rapid progression. Part II: Biomarkers and research methods]
1Klinik und Poliklinik für Psychiatrie und Psychotherapie, Technische Universität München. hans.foerstl@lrz.tu-muenchen.de
Deutsche Medizinische Wochenschrift (1946)
|January 15, 2009
Summary
Long-term studies are crucial for evaluating early dementia interventions. Biomarkers and advanced imaging show promise but require further validation for practical clinical use in dementia research.
Area of Science:
- Neuroscience
- Biomarker Research
- Clinical Trials
Context:
- Dementia progression is slow, necessitating long-term studies.
- Large sample sizes and logistical challenges are common in dementia research.
- High dropout rates can impact study validity.
Purpose:
- To examine the efficacy of preventive and early therapeutic interventions for dementia.
- To assess the utility of biomarkers in monitoring intervention effects.
- To investigate the potential of advanced imaging techniques in preclinical dementia.
Summary:
- Biomarkers such as beta-amyloid and tau proteins are under investigation for monitoring early Alzheimer's disease interventions.
- Functional and structural imaging methods show promising early results but require further validation.
- Current cerebrospinal fluid (CSF) markers may lack sensitivity for tracking early intervention effects in dementia.
Impact:
- Findings will inform the development of more sensitive biomarkers for dementia research.
- This research could lead to improved monitoring of early dementia interventions.
- Validated imaging and biomarker techniques will aid in clinical trial design and patient selection for dementia therapies.
Related Concept Videos
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...